01 July 1999
Diagnostic value of the Pressure Relief Index in chronic venous insufficiency patients
Marek Ciecierski, Arkadiusz Jawień, Tomasz GrzelaMed Sci Monit 1999; 5(4): CR697-702 :: ID: 503492
Abstract
We evaluated pressure relief index (PRI) values in patients with chronic venous insufficiency. The study group comprised 15 healthy subjects and 71 patients. We determined the venous pressure in the orthostatic position, during exersion and following exercise. We repeated the procedure after the placement of a pressure cuff, located above the ankles. We estimated the pressure at rest (p-s), the lowest pressure during exersion (p-min.), the time needed to obtain normal pressure values (RT), 90% of RT and the Pressure Relief Index (PRI). The following groups were formed: group I - 19 healthy limbs, group II Ñ 17 limbs with superficial varices, group III- 4 limbs with superficial varices and varicose ulcers, group IV - 22 limbs with the postphlebitis syndrome, without varicose ulcers, group V - 43 limbs with the postphlebitis syndrome and ulcerations. Curves demonstrated the groups distribution of venous pressures. PRI values of healthy subjects amounted to an average of 1826 and were statistically higher, in comparison with the other groups (p < 0.001). PRI values were as follows: group II - 915, group III - 377.5, group IV - 530.6, group V - 176.6. p < 0.05 was considered as stastically significant. During the cuff test PRI values in group II increased to 1399.5, contrary to group III and IV values. A similar difference was observed between group V (PRI - 286.7) and group IV. PRI values below 300 consisted with a70% risk of varicose ulcerations.
Keywords: pressure relief index, Diagnosis, Venous Insufficiency
Editorial
01 May 2024 : Editorial
Editorial: First Regulatory Approval for Adoptive Cell Therapy with Autologous Tumor-Infiltrating Lymphocytes (TILs) – Lifileucel (Amtagvi)DOI: 10.12659/MSM.944927
Med Sci Monit 2024; 30:e944927
In Press
12 Mar 2024 : Clinical Research
Metabolomic Alterations in Methotrexate Treatment of Moderate-to-Severe PsoriasisMed Sci Monit In Press; DOI: 10.12659/MSM.943360
14 Mar 2024 : Clinical Research
Renal Dysfunction Increases Risk of Adverse Cardiovascular Events in 5-Year Follow-Up Study of Intermediate...Med Sci Monit In Press; DOI: 10.12659/MSM.943956
15 Mar 2024 : Clinical Research
Impact of One-Lung Ventilation on Oxygenation and Ventilation Time in Thoracoscopic Heart Surgery: A Compar...Med Sci Monit In Press; DOI: 10.12659/MSM.943089
14 Mar 2024 : Clinical Research
Differential DHA and EPA Levels in Women with Preterm and Term Births: A Tertiary Hospital Study in IndonesiaMed Sci Monit In Press; DOI: 10.12659/MSM.943895
Most Viewed Current Articles
17 Jan 2024 : Review article
Vaccination Guidelines for Pregnant Women: Addressing COVID-19 and the Omicron VariantDOI :10.12659/MSM.942799
Med Sci Monit 2024; 30:e942799
14 Dec 2022 : Clinical Research
Prevalence and Variability of Allergen-Specific Immunoglobulin E in Patients with Elevated Tryptase LevelsDOI :10.12659/MSM.937990
Med Sci Monit 2022; 28:e937990
16 May 2023 : Clinical Research
Electrophysiological Testing for an Auditory Processing Disorder and Reading Performance in 54 School Stude...DOI :10.12659/MSM.940387
Med Sci Monit 2023; 29:e940387
01 Jan 2022 : Editorial
Editorial: Current Status of Oral Antiviral Drug Treatments for SARS-CoV-2 Infection in Non-Hospitalized Pa...DOI :10.12659/MSM.935952
Med Sci Monit 2022; 28:e935952